Admission Date:  [**2190-5-16**]              Discharge Date:   [**2190-5-20**]  Date of Birth:  [**2141-8-16**]             Sex:   F  Service: MEDICINE  Allergies: Sulfa (Sulfonamide Antibiotics) / Adhesive Bandage  Attending:[**First Name3 (LF) 12131**] Chief Complaint: Chief Complaint:  presyncope, palpitations  Reason for MICU transfer:  saddle PE   Major Surgical or Invasive Procedure: None  History of Present Illness: Ms. [**Known lastname **] is a 48F with h/o stage 4 jejunal adenocarcinoma with peritoneal mets, HTN, DM2, HLD, followed by Dr [**Last Name (STitle) **], Yergulun, on palliative chemotherapy with FOLFIRI/bevacizumab.
She presented to [**Hospital 1562**] hospital, where an ultrasound showed new DVT, and she was started on heparin 1400/hr.
Past Medical History: Past Medical History: Metastatic jejunal adenoCA HTN DM2 HLD  ONCOLOGIC HISTORY: - Early [**2189**]: Began experiencing vague abdominal discomfort, bloating, intermittent nausea/vomiting, and weight loss from poor PO intake.
He thus performed a resection of that segment of small bowel measuring 8.1 cm in length.
Of note, there was also adenoma with high-grade glandular dysplasia adjacent to an overlying epicenter of the invasive mass.
- [**2188-4-29**]: Began cycle 1 of modified FOLFOX6, however CEA noted to be quickly rising so no further treatment was given at the time.
Chose to take a treatment break after her 12th (C7D1) dose on [**2189-12-7**].
DISCHARGE LABS  [**2190-5-20**] 05:57AM [**Month/Day/Year 3143**] WBC-3.4* RBC-3.35* Hgb-10.4* Hct-30.9* MCV-92 MCH-31.0 MCHC-33.5 RDW-15.1 Plt Ct-159 [**2190-5-20**] 05:57AM [**Month/Day/Year 3143**] Neuts-58.6 Lymphs-32.8 Monos-5.2 Eos-2.9 Baso-0.4 [**2190-5-20**] 05:57AM [**Month/Day/Year 3143**] Glucose-114* UreaN-8 Creat-0.8 Na-141 K-3.6 Cl-105 HCO3-28 AnGap-12 [**2190-5-19**] 04:06AM [**Month/Day/Year 3143**] ALT-7 AST-15 LD(LDH)-301* AlkPhos-69 TotBili-0.2 [**2190-5-20**] 05:57AM [**Month/Day/Year 3143**] Calcium-8.0* Phos-3.6 Mg-2.1   Brief Hospital Course: Ms. [**Known lastname **] is a 48F with h/o stage 4 jejunal adenocarcinoma with peritoneal mets on palliative chemotherapy with FOLFIRI/bevacizumab, HTN, DM2, HLD, who p/w LE pain and palpitations, found to have extensive PE's involving all lobes and a saddle embolus.
She was commenced on a heparin gtt at [**Hospital 1562**] hospital after presenting there with LE pain and a brief episode of lightheadedness.
At the [**Hospital1 18**] ED, Cards, cardiac surgery, and cardiothoracic surgery were all consulted after the PE's were found on CTA, and thrombolysis and thrombectomy were both considered but not undertaken.
In the [**Hospital Unit Name 153**], she was maintained on a heparin gtt with goal PTT 80-100.
On 5/14am, she became hypotensive and presyncopal, requiring a dopamine gtt and arterial line placement; cardiology was reconsulted and systemic TPA was given, with a plan to pursue catheter based thrombolysis only if systemic thrombolysis failed.
Serial HCTs were monitored after patient received TPA and patient's HCT remained stable.
Although this is a possibility, the decision was made to not pursue this intervention at this time.
She was discharged on Lovenox 100mg [**Hospital1 **].
CHRONIC ISSUES:  # jejeunal adenocarcinoma with peritoneal mets: She is on palliative chemotherapy with FOLFIRI/bevacizumab.
# HTN: held home lisinopril while admitted  # DM2: ISS while admitted  # HLD: held home Tricor while admitted  TRANSITIONS OF CARE: CODE STATUS: FULL CODE CONTACT: husband PENDING STUDIES:none ISSUES TO ADDRESS AT FOLLOW UP: anticoagulation with Lovenox treamtent of cancer.
Medications on Admission: Home Medications:  (reviewed with pt [**2190-5-17**]) Tricor Lisinopril 20mg daily Metformin 500mg [**Hospital1 **] ASA 81mg daily Loratadine 10mg daily   Discharge Medications: 1. enoxaparin 100 mg/mL Syringe Sig: One (1)  Subcutaneous Q12H (every 12 hours).
Tricor 145 mg Tablet Sig: One (1) Tablet PO once a day.
3. fluticasone 50 mcg/actuation Spray, Suspension Sig: One (1) Nasal once a day as needed for allergy symptoms.
4. lisinopril 20 mg Tablet Sig: One (1) Tablet PO once a day.
5. metformin 500 mg Tablet Sig: One (1) Tablet PO twice a day.
6. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO once a day.
7. loratadine 10 mg Tablet Sig: One (1) Tablet PO once a day as needed for allergy symptoms.
Discharge Instructions: Dear Mrs. [**Known lastname **], You were admitted for a large [**Known lastname **] clot in your lungs.
You received clot-busting medication and you did not experience bleeding complications.
Please note the following changes to your medications: - START Lovenox  Followup Instructions: Department: HEMATOLOGY/ONCOLOGY When: MONDAY [**2190-6-14**] at 11:00 AM With: [**First Name4 (NamePattern1) 488**] [**Last Name (NamePattern1) 6401**], MD [**Telephone/Fax (1) 22**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) 24**] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage  Department: HEMATOLOGY/ONCOLOGY When: MONDAY [**2190-6-14**] at 11:00 AM With: [**Name6 (MD) **] [**Last Name (NamePattern4) 7634**], MD [**Telephone/Fax (1) 22**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) 24**] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage  Department: HEMATOLOGY/ONCOLOGY When: MONDAY [**2190-6-14**] at 12:00 PM With: [**First Name8 (NamePattern2) 2191**] [**Last Name (NamePattern1) **], RN [**Telephone/Fax (1) 22**] Building: [**Hospital6 29**] [**Location (un) 24**] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage
